Loading...
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
Pancreatic cancer is one of the deadliest causes of cancer-related death in the United States, with a 5-year overall survival rate of 6 to 8%. These statistics suggest that immediate medical attention is needed. Gemcitabine (GEM) is the gold standard first-line single chemotherapy agent for pancreat...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920852/ https://ncbi.nlm.nih.gov/pubmed/31689930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110574 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|